Edison Pharmaceuticals of San Jose, CA, has raised $6.2 million in its first round: $2.8 million from a stock offering and $3.4 million in foundation grants. Paul Avery led the first round. Meanwhile, Galileo Pharmaceuticals has agreed to take an equity stake in the biotech company in exchange for a technology transfer and screening agreement. Release